Current
13.6×
5-Year Average
11.7×
All-Time High
16.2×
All-Time Low
5.5×
EV/EBITDA daily chart for Labcorp Holdings (LH)
Jun 8, 2021 – Jun 5, 2026 · 1,255 trading days
Historical EV/EBITDA for Labcorp Holdings (LH) from 2001 to 2025
| 2025 | $20.70B | $2.01B | 13.6× | -0.2× | |
| 2024 | $19.17B | $1.81B | 13.8× | -1.2× | |
| 2023 | $19.30B | $1.65B | 15.0× | +3.9× | |
| 2022 | $17.90B | $2.15B | 11.1× | +3.9× | |
| 2021 | $25.72B | $4.28B | 7.2× | -0.3× | |
| 2020 | $17.05B | $3.01B | 7.5× | -2.6× | |
| 2019 | $14.13B | $2.07B | 10.1× | +1.6× | |
| 2018 | $10.88B | $1.93B | 8.5× | -2.1× | |
| 2017 | $14.00B | $1.93B | 10.6× | +1.7× | |
| 2016 | $11.39B | $1.89B | 8.9× | -1.1× | |
| 2015 | $10.76B | $1.65B | 9.9× | +1.3× | |
| 2014 | $7.84B | $1.19B | 8.7× | +0.8× | |
| 2013 | $6.73B | $1.18B | 7.9× | +0.1× | |
| 2012 | $6.96B | $1.17B | 7.8× | +0.0× | |
| 2011 | $7.17B | $1.19B | 7.8× | -0.8× | |
| 2010 | $7.57B | $1.11B | 8.6× | +1.2× | |
| 2009 | $6.79B | $1.09B | 7.4× | +0.0× | |
| 2008 | $5.95B | $1.01B | 7.4× | -1.6× | |
| 2007 | $7.35B | $990.40M | 8.9× | -1.2× | |
| 2006 | $7.70B | $851.40M | 10.2× | +1.1× | |
| 2005 | $6.06B | $784.80M | 9.1× | +0.1× | |
| 2004 | $5.92B | $736.30M | 9.0× | +1.2× | |
| 2003 | $4.47B | $670.80M | 7.8× | +1.7× | |
| 2002 | $2.89B | $554.30M | 6.1× | -5.0× | |
| 2001 | $4.86B | $471.60M | 11.1× | — |
- 202513.6×
- 202413.8×
- 202315.0×
- 202211.1×
- 20217.2×
- 20207.5×
- 201910.1×
- 20188.5×
- 201710.6×
- 20168.9×
- 20159.9×
- 20148.7×
- 20137.9×
- 20127.8×
- 20117.8×
- 20108.6×
- 20097.4×
- 20087.4×
- 20078.9×
- 200610.2×
- 20059.1×
- 20049.0×
- 20037.8×
- 20026.1×
- 200111.1×
About EV/EBITDA at Labcorp Holdings (LH)
Labcorp Holdings (LH) EV/EBITDA ratio is 13.6× as of June 5, 2026. The 5-year average is 11.7×. The sector median currently stands at 15.0×. The current ratio is at the 46th percentile of its own 10-year history.
Labcorp Holdings (LH) historical EV/EBITDA ratio has ranged from a low of 5.5× (2022) to a high of 16.2× (2025) in the available daily series.
The EV/EBITDA ratio (the enterprise multiple) compares enterprise value (EV) to trailing twelve-month (TTM) EBITDA. EV is calculated as market capitalisation + total debt − cash & short-term investments. Because EV/EBITDA is capital-structure-neutral and ignores non-cash depreciation and amortisation, it is the standard multiple used in M&A and for cross-company or cross-border comparisons. Note: this calculation uses a simplified EV (minority interest and preferred equity excluded due to data availability), consistent with most public financial-data providers.
Labcorp Holdings EV/EBITDA by Year
Labcorp Holdings EV/EBITDA 2025: 13.6×
Labcorp Holdings (LH) EV/EBITDA ratio in 2025 was 13.6×, contracted from 13.8× the prior year.
Labcorp Holdings EV/EBITDA 2024: 13.8×
Labcorp Holdings (LH) EV/EBITDA ratio in 2024 was 13.8×, contracted from 15.0× the prior year.
Labcorp Holdings EV/EBITDA 2023: 15.0×
Labcorp Holdings (LH) EV/EBITDA ratio in 2023 was 15.0×, expanded from 11.1× the prior year.
Labcorp Holdings EV/EBITDA 2022: 11.1×
Labcorp Holdings (LH) EV/EBITDA ratio in 2022 was 11.1×, expanded from 7.2× the prior year.
Labcorp Holdings EV/EBITDA 2021: 7.2×
Labcorp Holdings (LH) EV/EBITDA ratio in 2021 was 7.2×.
EV is calculated as Market Cap + Total Debt − Cash & Short-Term Investments (simplified). Minority interest and preferred equity are excluded due to data availability. This is consistent with the methodology used by most public financial data providers.
Sector peers by EV/EBITDA — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by EV/EBITDA — table
Healthcare peers of Labcorp Holdings (LH), ranked by EV/EBITDA ratio.
| 14.0× | |
| 13.9× | |
| 13.6× | |
| 13.2× | |
| 12.9× | |
| 12.9× | |
| 12.7× | |
| 12.4× | |
| 12.0× | |
| 11.7× | |
| 11.5× | |
| 11.5× | |
| 11.2× | |
| 10.5× | |
| 10.0× | |
| 8.8× | |
| 8.5× | |
| 8.2× | |
| 7.9× | |
| 7.8× | |
| 6.8× | |
| 6.5× | |
| 5.8× | |
| 5.7× | |
| 4.5× |
- 13.6×
- 13.2×
- 12.9×
- 12.4×
- 12.0×
- 11.7×
- 11.5×
- 10.5×
- 10.0×
- 8.5×
- 8.2×
- 7.9×
- 7.8×
- 5.8×
- 4.5×
Frequently asked questions
Labcorp Holdings (LH) Key Financials
Charts, filings, and peer comparison for every metric